linkedin post 2014-09-01 06:24:45

REGULATORY POSITION ON PHAGES. “Earlier FDA-approved clinical uses in the 1970s, 1980s, and 1990s involved phage phi X174 … for nontherapeutic purposes to patients with Down syndrome … and other immunodeficiencies … Agency officials concluded that the vaccines were safe and allowed their continued use.”

http://lnkd.in/digJGBR

View in LinkedIn